Nihon Kohden (OTCMKTS:NHNKY - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.30 earnings per share for the quarter, Zacks reports. Nihon Kohden had a net margin of 7.71% and a return on equity of 15.08%.
Nihon Kohden Stock Down 6.6 %
OTCMKTS:NHNKY traded down $1.04 during mid-day trading on Friday, reaching $14.76. 3,601 shares of the stock were exchanged, compared to its average volume of 5,447. Nihon Kohden has a 1 year low of $10.06 and a 1 year high of $20.00. The company has a 50 day simple moving average of $14.06 and a 200-day simple moving average of $14.20. The stock has a market capitalization of $2.52 billion, a P/E ratio of 14.76 and a beta of -0.12.
About Nihon Kohden
(
Get Free Report)
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers.
Featured Articles
Before you consider Nihon Kohden, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nihon Kohden wasn't on the list.
While Nihon Kohden currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
